SCHEMBL6890807

SCHEMBL6890807

O=C(O)CSc1nnc[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.49
▸ PRKAG1 P54619 1/20 0.41
▸ PRKAA2 P54646 1/20 0.41
▸ PRKAB1 Q9Y478 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ FFAR1 O14842 1/20 0.39
▸ CSNK2A2 P19784 2/20 0.39
▸ CSNK2A1 P68400 2/20 0.39
▸ CSNK2B P67870 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PHGDH O43175 1/20 0.38
▸ NOTUM Q6P988 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11525465 0.83 KDM4E (0.33) KMT2AKDM4ETDP1
SCHEMBL3104623 0.73 LMNA (0.39) PRKAG1PRKAA2PRKAB1CYP2C19
SCHEMBL4290130 0.69 KMT2A (0.53) KMT2APRKAG1PRKAA2PRKAB1KDM4E
SCHEMBL6403299 0.68 KMT2A (0.63) KMT2AALDH1A1CYP1A2CYP2C19POLB
SCHEMBL9196543 0.67 KMT2A (0.50) KMT2APRKAG1PRKAA2PRKAB1KDM4E
SCHEMBL16378624 0.65 CYP2C9 (0.37) CYP1A2CYP2C19GAA
Tiazotic Acid SCHEMBL6409061 0.65 POLB (0.51) KMT2APRKAG1PRKAA2PRKAB1KDM4E
SCHEMBL17214886 0.65 KMT2A (0.41) KMT2APRKAG1PRKAA2PRKAB1KDM4E
SCHEMBL15925206 0.63 KMT2A (0.50) KMT2APRKAG1PRKAA2PRKAB1KDM4E
SCHEMBL5912924 0.61 POLB (0.47) KMT2ARAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217577-B1 NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES INC (US) 2014-08-06 — — EP disclosed
US-20040082079-A1 Low affinity screening method GRAFFINITY PHARMACEUTICALS AG. (DE) 2004-04-29 — — US disclosed
EP-1360489-A1 LOW AFFINITY SCREENING METHOD Graffinity Pharmaceuticals Aktiengesellschaft (DE) 2003-11-12 — — EP disclosed
WO-2002063299-A1 LOW AFFINITY SCREENING METHOD GRAFFINITY PHARMACEUTICALS AG (DE) 2002-08-15 — — WO disclosed
Send feedback